---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-026815"
form_type: "8-K"
ticker: "TLPH"
cik: "0001427925"
company_name: "TALPHERA, INC."
filed_at: "2024-08-14T23:59:59+00:00"
generated_at: "2026-05-31T09:17:40.095909+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Talphera Q2 net loss $3.8M; CMO Palmer retiring Oct 1, succeeded by Dr. Aslam

## Summary
- Net loss $3.8M ($0.15 loss per share) vs $4.4M ($0.40 loss) in Q2 2023; cash $14.0M.
- NEPHRO CRRT registrational study screening initiated; enrolling 166 patients at up to 14 U.S. sites.
- Pamela Palmer, co-founder and CMO, to retire Oct 1; Dr. Shakil Aslam (current CDO) to become CMO.
- Combined R&D and SG&A expenses rose to $4.3M from $4.2M year-over-year; no DSUVIA expenses.

## SEC filing metadata
- accession: 0001437749-24-026815
- form_type: 8-K
- ticker: TLPH
- cik: 0001427925
- company_name: TALPHERA, INC.
- filed_at: 2024-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427925/000143774924026815/0001437749-24-026815-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427925/000143774924026815/acrx20240814_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-026815
- JSON: https://secwatch.observer/filing/0001437749-24-026815.json
- Plain text: https://secwatch.observer/filing/0001437749-24-026815.txt

## Key facts
- Executive change
  Shakil Aslam was appointed as Chief Medical Officer at TALPHERA, INC..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: Upon Dr. Palmer’s retirement, Dr. Shakil Aslam, currently the Company’s Chief Development Officer, will assume the position of the Company’s Chief Medical Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1427925/000143774924026815/0001437749-24-026815-index.htm
- Executive change
  Pamela P. Palmer resigned as Chief Medical Officer at TALPHERA, INC..
  - Action: resigned
  - Role: Chief Medical Officer
  source text: On August 12, 2024, Pamela P. Palmer, MD, PhD, the Company’s Chief Medical Officer and co-founder, notified the Company that she plans to retire and resign from the Company effective October 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1427925/000143774924026815/0001437749-24-026815-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.